Variant report

Variant	nsv600038
Chromosome Location	chr5:150950853-150955127
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CCNT2	chr5:150951260-150951384	K562	blood:	n/a	n/a
2	CTCF	chr5:150952120-150952270	NHEK	skin:	n/a	n/a
3	E2F4	chr5:150955088-150955125	MCF10A-Er-Src	breast:	n/a	n/a
4	E2F4	chr5:150954107-150954492	MCF10A-Er-Src	breast:	n/a	n/a
5	E2F6	chr5:150950502-150950892	H1-hESC	embryonic stem cell:	n/a	chr5:150950687-150950694 chr5:150950687-150950694 chr5:150950686-150950695 chr5:150950687-150950694 chr5:150950686-150950698
6	E2F6	chr5:150950195-150950982	H1-hESC	embryonic stem cell:	n/a	chr5:150950687-150950694 chr5:150950687-150950694 chr5:150950686-150950695 chr5:150950687-150950694 chr5:150950686-150950698
7	EP300	chr5:150948268-150951579	ECC-1	luminal epithelium:	n/a	n/a
8	ESR1	chr5:150950945-150951363	ECC-1	luminal epithelium:	n/a	n/a
9	ESR1	chr5:150950928-150951375	ECC-1	luminal epithelium:	n/a	n/a
10	FOS	chr5:150952359-150952597	MCF10A-Er-Src	breast:	n/a	n/a
11	FOS	chr5:150953998-150954514	MCF10A-Er-Src	breast:	n/a	chr5:150954343-150954350 chr5:150954341-150954350
12	FOS	chr5:150954124-150954506	MCF10A-Er-Src	breast:	n/a	chr5:150954343-150954350 chr5:150954341-150954350
13	FOS	chr5:150951994-150952110	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr5:150954000-150954513	MCF10A-Er-Src	breast:	n/a	chr5:150954343-150954350 chr5:150954341-150954350
15	FOS	chr5:150952008-150952541	MCF10A-Er-Src	breast:	n/a	chr5:150952301-150952315
16	FOS	chr5:150954136-150954492	MCF10A-Er-Src	breast:	n/a	chr5:150954343-150954350 chr5:150954341-150954350
17	FOS	chr5:150951918-150952670	MCF10A-Er-Src	breast:	n/a	chr5:150952301-150952315
18	FOS	chr5:150951751-150952629	MCF10A-Er-Src	breast:	n/a	chr5:150952301-150952315
19	MAX	chr5:150949934-150951424	ECC-1	luminal epithelium:	n/a	chr5:150950813-150950822
20	MAX	chr5:150949571-150951459	ECC-1	luminal epithelium:	n/a	chr5:150950813-150950822 chr5:150949823-150949832
21	MYC	chr5:150950997-150951056	MCF10A-Er-Src	breast:	n/a	n/a
22	MYC	chr5:150952079-150952732	MCF10A-Er-Src	breast:	n/a	n/a
23	MYC	chr5:150952052-150952673	MCF10A-Er-Src	breast:	n/a	n/a
24	NFIC	chr5:150950712-150951521	ECC-1	luminal epithelium:	n/a	n/a
25	NFIC	chr5:150948291-150951634	ECC-1	luminal epithelium:	n/a	n/a
26	POLR2A	chr5:150950847-150951355	ECC-1	luminal epithelium:	n/a	n/a
27	POLR2A	chr5:150952276-150952525	MCF10A-Er-Src	breast:	n/a	n/a
28	POLR2A	chr5:150953389-150953871	ECC-1	luminal epithelium:	n/a	n/a
29	POLR2A	chr5:150949609-150951629	ECC-1	luminal epithelium:	n/a	n/a
30	POLR2A	chr5:150952184-150952566	ECC-1	luminal epithelium:	n/a	n/a
31	POLR2A	chr5:150954117-150954193	MCF10A-Er-Src	breast:	n/a	n/a
32	POLR2A	chr5:150951404-150951459	MCF10A-Er-Src	breast:	n/a	n/a
33	POLR2A	chr5:150954081-150954314	MCF10A-Er-Src	breast:	n/a	n/a
34	POLR2A	chr5:150952149-150952485	MCF10A-Er-Src	breast:	n/a	n/a
35	RCOR1	chr5:150952703-150952839	K562	blood:	n/a	n/a
36	REST	chr5:150952202-150952595	MCF-7	breast:	n/a	n/a
37	RFX5	chr5:150954424-150954433	K562	blood:	n/a	n/a
38	STAT3	chr5:150954042-150954484	MCF10A-Er-Src	breast:	n/a	chr5:150954342-150954351 chr5:150954316-150954330 chr5:150954317-150954328
39	STAT3	chr5:150951919-150952825	MCF10A-Er-Src	breast:	n/a	chr5:150952428-150952437 chr5:150952422-150952442 chr5:150952427-150952436 chr5:150952426-150952437 chr5:150952428-150952436
40	STAT3	chr5:150951821-150952847	MCF10A-Er-Src	breast:	n/a	chr5:150952428-150952437 chr5:150952422-150952442 chr5:150952427-150952436 chr5:150952426-150952437 chr5:150952428-150952436
41	STAT3	chr5:150953775-150954724	MCF10A-Er-Src	breast:	n/a	chr5:150954580-150954588 chr5:150954342-150954351 chr5:150954316-150954330 chr5:150954317-150954328
42	STAT3	chr5:150951520-150952729	MCF10A-Er-Src	breast:	n/a	chr5:150952428-150952437 chr5:150952422-150952442 chr5:150952427-150952436 chr5:150952426-150952437 chr5:150952428-150952436
43	STAT3	chr5:150953993-150954502	MCF10A-Er-Src	breast:	n/a	chr5:150954342-150954351 chr5:150954316-150954330 chr5:150954317-150954328
44	STAT3	chr5:150953889-150954595	MCF10A-Er-Src	breast:	n/a	chr5:150954580-150954588 chr5:150954342-150954351 chr5:150954316-150954330 chr5:150954317-150954328
45	STAT3	chr5:150951140-150951169	MCF10A-Er-Src	breast:	n/a	n/a
46	STAT3	chr5:150951764-150952660	MCF10A-Er-Src	breast:	n/a	chr5:150952428-150952437 chr5:150952422-150952442 chr5:150952427-150952436 chr5:150952426-150952437 chr5:150952428-150952436
47	TCF12	chr5:150948287-150951635	ECC-1	luminal epithelium:	n/a	chr5:150950155-150950165 chr5:150951194-150951201
48	TCF12	chr5:150950744-150951547	ECC-1	luminal epithelium:	n/a	chr5:150951194-150951201
49	ZNF143	chr5:150952632-150952840	H1-hESC	embryonic stem cell:	n/a	n/a
50	ZNF143	chr5:150952623-150952793	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:150952384..150954279-chr5:150993014..150994959,2	MCF-7	breast:
2	chr5:150949333..150952291-chr5:151000084..151002404,2	MCF-7	breast:
3	chr5:150949275..150951752-chr5:151137668..151139701,2	K562	blood:
4	chr5:150951137..150953808-chr5:151149761..151151549,2	K562	blood:
5	chr5:150947375..150949317-chr5:150951116..150952783,2	K562	blood:
6	chr5:150948647..150952629-chr5:150970748..150974404,4	MCF-7	breast:
7	chr5:150951358..150953690-chr5:150997302..150999283,2	MCF-7	breast:
8	chr5:150950232..150951828-chr5:150992759..150995006,2	MCF-7	breast:
9	chr5:150949470..150952211-chr5:150958873..150961683,3	MCF-7	breast:

Variant related genes	Relation type
FAT2	TF binding region
ENSG00000145907	chromatin interactions
ENSG00000177556	chromatin interactions
ENSG00000086570	chromatin interactions

Extended variants
information (count: 173 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:173 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10060613	chr5:150950853-150950854	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs10060662	chr5:150950870-150950871	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs536234281	chr5:150950880-150950881	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs141388214	chr5:150950899-150950900	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs572992268	chr5:150950903-150950904	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs540303258	chr5:150950935-150950936	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs558481529	chr5:150950937-150950938	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs78165359	chr5:150950945-150950946	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs544225629	chr5:150950976-150950977	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs562779054	chr5:150951009-150951010	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs143396919	chr5:150951036-150951037	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs542625412	chr5:150951039-150951040	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs182921283	chr5:150951057-150951058	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs60907456	chr5:150951066-150951067	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs546651665	chr5:150951070-150951071	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs571789753	chr5:150951173-150951174	Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs532740350	chr5:150951249-150951250	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs551022248	chr5:150951264-150951265	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs569519071	chr5:150951285-150951286	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs374748895	chr5:150951326-150951327	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs10039591	chr5:150951368-150951369	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs554628524	chr5:150951376-150951377	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs570933100	chr5:150951412-150951413	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs527810468	chr5:150951418-150951419	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs566430072	chr5:150951429-150951430	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs200787050	chr5:150951483-150951484	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs79634797	chr5:150951489-150951490	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs151133249	chr5:150951497-150951498	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs1432865	chr5:150951581-150951582	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs576991638	chr5:150951591-150951592	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs115154272	chr5:150951598-150951599	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs556047843	chr5:150951643-150951644	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs574410597	chr5:150951693-150951694	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs1432864	chr5:150951743-150951744	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs140074129	chr5:150951787-150951788	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs550057668	chr5:150951839-150951840	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs112976184	chr5:150951852-150951853	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs7732813	chr5:150951873-150951874	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs540419670	chr5:150951894-150951895	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs565360706	chr5:150951962-150951963	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs532633092	chr5:150951983-150951984	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs114936518	chr5:150952033-150952034	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs569324461	chr5:150952056-150952057	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs530421231	chr5:150952118-150952119	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs7719117	chr5:150952122-150952123	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs566518269	chr5:150952129-150952130	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs7737011	chr5:150952159-150952160	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs558403651	chr5:150952187-150952188	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs376966631	chr5:150952198-150952199	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs7737419	chr5:150952212-150952213	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	19377443	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18194544	CNVD
Renal cell carcinoma	18592004	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Hyperekplexia	16941485	CNVD
Myelofibrosis	22110671	CNVD
Crohn''s disease	20877625	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	17603634	CNVD
Crohn''s disease	20106866	CNVD
Breast cancer	20409316	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:48 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:150948400-150951200	Enhancers	Esophagus	oesophagus
2	chr5:150948400-150953600	Enhancers	Breast Myoepithelial Primary Cells	Breast
3	chr5:150948400-150953600	Enhancers	Fetal Thymus	thymus
4	chr5:150948600-150951000	Enhancers	Placenta Amnion	Placenta Amnion
5	chr5:150948600-150951400	Enhancers	Placenta	Placenta
6	chr5:150948600-150952600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr5:150949000-150951400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr5:150949600-150951600	Flanking Active TSS	NHEK	skin
9	chr5:150949800-150951000	Enhancers	iPS-18 Cell Line	embryonic stem cell
10	chr5:150949800-150951200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
11	chr5:150949800-150951200	Transcr. at gene 5' and 3'	Foreskin Keratinocyte Primary Cells skin02	Skin
12	chr5:150949800-150951400	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
13	chr5:150950000-150951200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr5:150950000-150951200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
15	chr5:150950200-150951200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr5:150950200-150951200	Enhancers	Spleen	Spleen
17	chr5:150950200-150951200	Flanking Active TSS	HMEC	breast
18	chr5:150950600-150951000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
19	chr5:150950600-150951200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
20	chr5:150950600-150951200	Enhancers	Right Ventricle	heart
21	chr5:150950800-150951000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr5:150950800-150951200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
23	chr5:150950800-150951600	Enhancers	Primary B cells from cord blood	blood
24	chr5:150950800-150951600	Enhancers	Primary B cells from peripheral blood	blood
25	chr5:150951000-150951200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
26	chr5:150951000-150951400	Enhancers	Colon Smooth Muscle	Colon
27	chr5:150951200-150951400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr5:150951200-150951400	Enhancers	Lung	lung
29	chr5:150951200-150951600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr5:150951200-150952000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr5:150951200-150952200	Enhancers	HMEC	breast
32	chr5:150951200-150953600	Weak transcription	Esophagus	oesophagus
33	chr5:150951200-150960400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr5:150951400-150953400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chr5:150951400-150959600	Weak transcription	Placenta	Placenta
36	chr5:150951600-150955800	Weak transcription	Primary B cells from cord blood	blood
37	chr5:150951600-150956400	Weak transcription	Primary B cells from peripheral blood	blood
38	chr5:150951600-150960400	Genic enhancers	NHEK	skin
39	chr5:150952000-150955800	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr5:150952200-150952400	Flanking Active TSS	HMEC	breast
41	chr5:150952400-150953600	Enhancers	HMEC	breast
42	chr5:150952600-150957000	Genic enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr5:150953400-150956000	Genic enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
44	chr5:150953600-150954000	Enhancers	Esophagus	oesophagus
45	chr5:150953600-150955400	Genic enhancers	HMEC	breast
46	chr5:150953600-150955600	Genic enhancers	Breast Myoepithelial Primary Cells	Breast
47	chr5:150953600-150956800	Weak transcription	Fetal Thymus	thymus
48	chr5:150954000-150959600	Weak transcription	Esophagus	oesophagus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links